1. Home
  2. Tobacco Products
  3. Products, Guidance & Regulations
  4. Market and Distribute a Tobacco Product
  5. Premarket Tobacco Product Applications
  6. Preparing and Submitting a Premarket Tobacco Product Application
  1. Premarket Tobacco Product Applications

Preparing and Submitting a Premarket Tobacco Product Application

On this page: 

Premarket tobacco product applications (PMTAs) must meet the content and format requirements described in the final PMTA rule: Premarket Tobacco Product Applications and Recordkeeping Requirements. Requirements for PMTAs include, among other things, submitting the appropriate FDA forms: 

Form FDA 4057b allows applicants to submit one PMTA for multiple products—such as e-liquids in varying sizes, nicotine strengths, or flavor combinations—as a grouped submission. Each product in a grouped submission is considered a separate, individual application and must include its own individual environmental assessment. Applicants should keep in mind that the content specific to each product in a grouped submission needs to be clearly specified.  

How Do I Prepare a Standard Premarket Tobacco Product Application (PMTA)? 

  • A PMTA includes (per section 910(b)(1)): 
    • Full reports of all information published or known to, or which should reasonably be known to, the applicant concerning investigations which have been made to show the health risks of such tobacco product and whether such tobacco product presents less risk than other tobacco products
    • Full statement of the components, ingredients, additives, and properties, and of the principle or principles of operation
    • Full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and when relevant, packing and installation
    • An identifying reference to any tobacco product standard, if applicable. If so, either:
      • Adequate information to show that such aspect of such tobacco product fully meets such tobacco product standard, or
      • Adequate information to justify any deviation from such standard
    • Samples of the tobacco product as required
    • Specimens of proposed labeling
    • Additional applicable required items per the final rule Refuse to Accept Procedures for Premarket Tobacco Submissions
  • FDA has interpreted these statutory requirements reflected in the PMTA final rule, under which a PMTA must contain the following sections (per 21 CFR 1114.7):
    • General information  
    • Descriptive information  
    • Product samples  
    • Labeling and description of marketing plans 
    • An environmental assessment prepared in accordance with the requirements of § 25.40 or a valid claim of categorical exclusion
      • FDA posted a programmatic environmental assessment related to the agency’s review of PMTAs for new tobacco products in the “other” category, such as nicotine pouches, lozenges, discs, tablets, gums, dissolvable tobacco products, and other nicotine infused products. This assessment may be cited by FDA staff conducting scientific reviews.
    • Summary  
    • Product formulation  
    • Manufacturing  
    • Health risk investigations  
    • The effect on the population as a whole  
    • Certification statement
  • To facilitate review, the application must comply with the PMTA format requirements (per 21 CFR 1114.7(b)). It must:

How Do I Prepare Supplemental PMTAs and Resubmissions?

In certain instances, it may be appropriate for an applicant to submit supplemental PMTAs or resubmissions. 

According to the PMTA rule, Premarket Tobacco Product Applications and Recordkeeping Requirements, a supplemental PMTA:

  • May be submitted in situations where an applicant is seeking authorization for a new tobacco product that is a modified version of a previously authorized tobacco product
  • May be submitted for modifications of a previously authorized tobacco product in order to demonstrate compliance with a tobacco product standard under section 907 of the FD&C Act
  • Allows the applicant to cross-reference applicable content from the previously submitted PMTA that received the marketing granted order
  • Must include a section containing full descriptions, data, and information of each modification to the new product, comparisons to the original product version, and a concluding summary of how the new product meets the requirements to receive a marketing granted order

According to the PMTA rule, a resubmission:

  • May be submitted to address application deficiencies following the issuance of a marketing denial order
  • May be for the same tobacco product which FDA issued a marketing denial order or a new tobacco product that results from modifications to the product necessary to address the deficiencies outlined in the marketing denial order
  • Allows the applicant to cross-reference content from the previously submitted PMTA that received the marketing denial order
  • Must include a section that lists and provides a separate response to each deficiency, including all data and information necessary to complete each response

Both supplemental PMTAs and resubmissions must include the following required FDA forms:

How Do I Prepare an Amendment?

When submitting a PMTA, applicants are expected to submit all required information, as outlined in section 910(b)(1) of the FD&C Act and 21 CFR Part 1114, to allow FDA to determine whether it should authorize the marketing of a new tobacco product. However, additional information may be needed for FDA to complete its review of a PMTA, so applicants are allowed to submit amendments to a pending application. 

FDA may, at any time after it receives and before it acts on an application, request an applicant submit additional information so the agency can complete its review of a PMTA. Similarly, an applicant may choose to submit an amendment with additional information on their own. Amendments may include information like a new study that is relevant to the PMTA or clarifications. 

Among other things, amendments must include:

  • Form FDA 4057a – Premarket Tobacco Product Application Amendment and General Correspondence Submission

    Complete this form directly in CTP Portal NextGen to help ensure a more user-friendly and efficient application submission process. A User Guide and instructional videos are available within CTP Portal NextGen to help applicants navigate the system.

    • Note:  Applicants may submit a PDF version of Form FDA 4057a if they are unable to submit online. Please note: Applicants must use the latest forms in their PMTA submissions. If applicants do not use the latest version of the forms or do not complete them properly, FDA generally intends to refuse to accept the application.
    • Get tips for completing Form FDA 4057a
  • The submission tracking number (STN) assigned to the application 
    • To locate your STN, refer to the latest letter from CTP or go to the Submissions tab on the CTP Portal NextGen homepage and select Published, as illustrated in the image below.
CTP Portal NexGen screenshot
  • A certification statement, as required by 21 CFR 1114.9(a) and described in 21 CFR 1114.7(m) 

To submit an amendment, follow the standard PMTA submission instructions. If responding to a deficiency (including requests), follow the instructions as outlined in your deficiency letter.

How Do I Submit PMTAs and Amendments? 

  1. Request an Industry Account Manager (IAM) account to establish a CTP Portal NextGen account, if your company does not already have an IAM.
  2. Prepare your submission electronically in the CTP Portal NextGen, or you can use FDA's eSubmitter software. NOTE: FDA will phase out the use of eSubmitter forms for PMTA and SE submissions. By Nov. 14, 2026, applicants should use the web-based forms in CTP Portal NextGen for PMTA and SE submissions (applicants may submit PDF versions if unable to submit online). After Nov.14, 2026, eSubmitter will no longer be available for PMTA and SE submissions.
  3. How Do I Upload eSubmitter Packages to CTP Portal NextGen?
  4. Submit online via CTP Portal NextGen.

Applicants may request a waiver from FDA to submit a PMTA in a format other than electronically in advance of submitting their applications. Waivers will be granted if use of electronic means is not reasonable for the applicant. 

Resources to Help With Preparing and Submitting a PMTA

Resource to submit and reference tobacco product master files:

Guidance to help applicants design and conduct tobacco product perception and intention (TPPI) studies:

Guidance for preparing and submitting a PMTA for electronic nicotine delivery systems (ENDS) and other e-cigarettes: 

Past public meetings: 

Back to Top